Management trajectories in the type 2 diabetes Integrated Delivery System project in Taiwan: Accounting for behavioral therapy, nutrition education and therapeutics

Hsing Yi Chang, Mark L. Wahlqvist, Wen Ling Liu, Meei-Shyuan Lee, Shyi Jang Shin, Yu Sheng Li, Chih Jen Chang, Chwen Tzuei Chang, Mao Tsu Fuh, Hung Jen Yang, Tong Yuan Tai, Chih Cheng Hsu

    Research output: Contribution to journalArticleResearchpeer-review

    18 Citations (Scopus)


    Background and aim: Glycated hemoglobin (HbA1c) assessment is basic to diabetes management. Little is done to describe the whole spectrum of the trajectory, its related temporal patterns of metabolic indices, and comorbidities. Methods and Results: This was a longitudinal study. In the Diabetes Management through Integrated Delivery System project in Taiwan, enrollees had diabetes, but no major comorbidities. They were randomized into intensive or conventional education (health, diet and exercise) groups. HbA1c was classified by a groupbased trajectory model on the basis of repeated six-monthly measurements. We analyzed data from 1091 subjects who had at least two measurements on HbA1c. HbA1c exhibited three distinct ranges of low (42-53 mmol/mol), intermediate (64-75 mmol/mol) and high (97 mmol/mol), all of which persisted for 4.5 years regardless of receiving intensive education or not. Temporal changes and a time-group interaction were found for triglycerides, total cholesterol, HDL-C and LDL-C. The high trajectory was associated with the major co-morbidities of retinopathy, nephropathy, neuropathy, stroke, hypoglycemia, and ketoacidosis. Patients in the intensive education group (62.4%), which were equally distributed in the three trajectories, had significantly lower HbA1cs (-0.14%= -1.5 mmol/mol, p=0.026). The intermediate trajectory patients with intensive education had HbA1cs higher than the low trajectory patients with conventional education (=0.189, p=0.033). Though not significant, a similar pattern was found for DM education in the high group (=0.223, p=0.154). Conclusions: Novel strategies beyond current education and pharmacotherapeutic regimens are needed to lower HbA1c at least 11 mmol/mol for the high HbA1c group to minimize comorbidities.
    Original languageEnglish
    Pages (from-to)592-606
    Number of pages15
    JournalAsia Pacific Journal of Clinical Nutrition
    Issue number4
    Publication statusPublished - 2014


    • glycemic control
    • diabetes complications
    • metabolic memory
    • trajectory
    • DMIDS

    Cite this